Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kristen Detweiler Short
Observed names:
K D Short,
K Detweiler Short,
K. Detweiler Short
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
OpenAlex ID:
A5111773471
Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease
2011
·
Martha Q. Lacy
, Jacob B. Allred
, et al.
·
Blood
·
223
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma
2011
·
K Detweiler Short
, S V Rajkumar
, et al.
·
Leukemia
·
209
Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)
2010
·
M Q Lacy
, S R Hayman
, et al.
·
Leukemia
·
198
Pomalidomide (CC4047) Plus Low Dose Dexamethasone (Pom/dex) Is Active and Well Tolerated in Lenalidomide Refractory Multiple Myeloma (MM).
2009
·
Martha Q. Lacy
, Morie A Gertz
, et al.
·
Blood
·
16
Efficacy of pomalidomide plus low-dose dexamethasone in multiple myeloma patients despite previous use of lenalidomide.
2011
·
J. Mikhael
, V. Rajkumar
, et al.
·
Journal of Clinical Oncology
·
7
Pomalidomide Plus Low-Dose Dexamethasone In Myeloma Refractory to Both Bortezomib and Lenalidomide: Comparison of Two Dosing Strategies In Dual-Refractory Disease
2010
·
Martha Lacy
, Sumithra Mandrekar
, et al.
·
Blood
·
6
Factors Predicting Early Mortality in Patients with Newly Diagnosed Multiple Myeloma,
2011
·
Vishal Rana
, Geetika Srivastava
, et al.
·
Blood
·
3
Increased Incidence of Extramedullary Plasmacytomas In Patients with Multiple Myeloma In the Era of Novel Therapy and Effect of Pomalidomide on Extramedullary Disease
2010
·
Kristen Detweiler Short
, S. Vincent Rajkumar
, et al.
·
Blood
·
2
Single-agent lenalidomide for newly diagnosed myeloma with on-demand dexamethasone: A phase II trial.
2011
·
F. Buadi
, M. Lacy
, et al.
·
Journal of Clinical Oncology
·
1
Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy
2010
·
Shirshendu Sinha
, Shaji Kumar
, et al.
·
Blood
Show more works
View as search
Works count:
10
Citation count:
665
H-index:
6
I10-index:
4
Year
Topic
Type